Kaleo, INC
Manufacturer of opioid overdose solution.
Based in VA
🤖
AI Overview
With $90K in lobbying spend across 3 quarterly filings, Kaleo, INC is an active lobbying client. Their lobbying covers 1 issue area.
$90K
Total Spend
1
Years Active
1
Firms Hired
1
Lobbyists Deployed
1
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $90K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Kaleo, INC disclosed contacting in their lobbying filings.
Office of the Vice President of the United StatesWhite House OfficeOffice of Natl Drug Control Policy (NDCP)
View all agency pressure data →What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Pharmacy
opioid epidemic, naloxone availability
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Healthcare Distribution Alliance (Formerly - Hdma)
$13.2M total spend
Community Oncology Alliance
$3.2M total spend
Healthcare Distribution Alliance (Healthcare Distribution Managment Assn.)
$2.9M total spend
Healthcare Distribution Alliance
$1.7M total spend
Society of Nuclear Medicine and Molecular Imaging
$1.5M total spend
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.